133 related articles for article (PubMed ID: 33875359)
1. Dose-Volume Predictors for Patient-reported Late Diarrhoea, Faecal Incontinence and Urgency after Pelvic Radiotherapy.
Jadon R; Hanna L; Parsons P; Staffurth J
Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):536-545. PubMed ID: 33875359
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of dose-volume predictors and constraints for late bowel toxicity following pelvic radiotherapy.
Jadon R; Higgins E; Hanna L; Evans M; Coles B; Staffurth J
Radiat Oncol; 2019 Apr; 14(1):57. PubMed ID: 30943992
[TBL] [Abstract][Full Text] [Related]
3. Faecal incontinence: A late side-effect of pelvic radiotherapy.
Putta S; Andreyev HJ
Clin Oncol (R Coll Radiol); 2005 Sep; 17(6):469-77. PubMed ID: 16149292
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported intestinal toxicity from whole pelvis intensity-modulated radiotherapy: First quantification of bowel dose-volume effects.
Sini C; Noris Chiorda B; Gabriele P; Sanguineti G; Morlino S; Badenchini F; Cante D; Carillo V; Gaetano M; Giandini T; Landoni V; Maggio A; Perna L; Petrucci E; Sacco V; Valdagni R; Rancati T; Fiorino C; Cozzarini C
Radiother Oncol; 2017 Aug; 124(2):296-301. PubMed ID: 28739383
[TBL] [Abstract][Full Text] [Related]
5. Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: An observational study.
Wedlake L; Thomas K; McGough C; Andreyev HJ
Eur J Cancer; 2008 Oct; 44(15):2212-7. PubMed ID: 18760593
[TBL] [Abstract][Full Text] [Related]
6. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
[TBL] [Abstract][Full Text] [Related]
7. Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: results of a large multicenter observational study.
Fellin G; Fiorino C; Rancati T; Vavassori V; Baccolini M; Bianchi C; Cagna E; Gabriele P; Mauro F; Menegotti L; Monti AF; Stasi M; Valdagni R
Radiother Oncol; 2009 Nov; 93(2):197-202. PubMed ID: 19828205
[TBL] [Abstract][Full Text] [Related]
8. Dose-effect relationships for individual pelvic floor muscles and anorectal complaints after prostate radiotherapy.
Smeenk RJ; Hoffmann AL; Hopman WP; van Lin EN; Kaanders JH
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):636-44. PubMed ID: 22137024
[TBL] [Abstract][Full Text] [Related]
9. Defining bowel dose volume constraints for bladder radiotherapy treatment planning.
McDonald F; Waters R; Gulliford S; Hall E; James N; Huddart RA
Clin Oncol (R Coll Radiol); 2015 Jan; 27(1):22-9. PubMed ID: 25445550
[TBL] [Abstract][Full Text] [Related]
10. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study.
Fiorino C; Fellin G; Rancati T; Vavassori V; Bianchi C; Borca VC; Girelli G; Mapelli M; Menegotti L; Nava S; Valdagni R
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1130-7. PubMed ID: 17881142
[TBL] [Abstract][Full Text] [Related]
11. Short-term Toxicity of High Dose Rate Brachytherapy in Prostate Cancer Patients with Inflammatory Bowel Disease.
Mohammed W; Hoskin P; Henry A; Gomez-Iturriaga A; Robinson A; Nikapota A
Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):534-538. PubMed ID: 30099986
[TBL] [Abstract][Full Text] [Related]
12. Prospective analysis of patient-reported late toxicity following pelvic radiotherapy for gynaecological cancer.
Barraclough LH; Routledge JA; Farnell DJ; Burns MP; Swindell R; Livsey JE; Davidson SE
Radiother Oncol; 2012 Jun; 103(3):327-32. PubMed ID: 22633812
[TBL] [Abstract][Full Text] [Related]
13. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
[TBL] [Abstract][Full Text] [Related]
14. Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity.
Fonteyne V; De Neve W; Villeirs G; De Wagter C; De Meerleer G
Radiother Oncol; 2007 Aug; 84(2):156-63. PubMed ID: 17692976
[TBL] [Abstract][Full Text] [Related]
15. Late fecal incontinence after high-dose radiotherapy for prostate cancer: better prediction using longitudinal definitions.
Fiorino C; Rancati T; Fellin G; Vavassori V; Cagna E; Casanova Borca V; Girelli G; Menegotti L; Monti AF; Tortoreto F; Delle Canne S; Valdagni R
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):38-45. PubMed ID: 21985939
[TBL] [Abstract][Full Text] [Related]
16. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.
Dutz A; Agolli L; Baumann M; Troost EGC; Krause M; Hölscher T; Löck S
Acta Oncol; 2019 Jun; 58(6):916-925. PubMed ID: 30882264
[No Abstract] [Full Text] [Related]
17. Faecal incontinence following radiotherapy for prostate cancer: a systematic review.
Maeda Y; Høyer M; Lundby L; Norton C
Radiother Oncol; 2011 Feb; 98(2):145-53. PubMed ID: 21257215
[TBL] [Abstract][Full Text] [Related]
18. Dose-volume effects for normal tissues in external radiotherapy: pelvis.
Fiorino C; Valdagni R; Rancati T; Sanguineti G
Radiother Oncol; 2009 Nov; 93(2):153-67. PubMed ID: 19765845
[TBL] [Abstract][Full Text] [Related]
19. Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study.
Bresolin A; Faiella A; Garibaldi E; Munoz F; Cante D; Vavassori V; Waskiewicz JM; Girelli G; Avuzzi B; Villa E; Magli A; Noris Chiorda B; Gatti M; Ferella L; Maggio A; Landoni V; Aimonetto S; Sini C; Rancati T; Sanguineti G; Valdagni R; Di Muzio N; Fiorino C; Cozzarini C
Radiother Oncol; 2021 May; 158():74-82. PubMed ID: 33639190
[TBL] [Abstract][Full Text] [Related]
20. Late gastrointestinal toxicity after radiotherapy for rectal cancer: a systematic review.
Sipaviciute A; Sileika E; Burneckis A; Dulskas A
Int J Colorectal Dis; 2020 Jun; 35(6):977-983. PubMed ID: 32296933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
